BLTE— BELITE BIO, INC

$159.16+3.02%

1 insider sold $1.8M in the last 30 days — 6.9x above baseline

Sell Velocity Score

6.93x

Sell Rate (30d)

366.67 sh/day

Sell Baseline Rate

—

Unique Sellers (30d)

Price Chart

Loading…

Recent Insider Transactions

Date	Owner	Role	Type	Shares	Price	Value	Owned After
2026-04-29	MATA NATHAN L.	Chief Scientific Officer	Sale	1,000	$155.82	$156K	5,666	View ↗
2026-04-28	MATA NATHAN L.	Chief Scientific Officer	Sale	1,000	$159.16	$159K	6,666	View ↗
2026-04-27	MATA NATHAN L.	Chief Scientific Officer	Sale	1,000	$162.64	$163K	7,666	View ↗
2026-04-24	MATA NATHAN L.	Chief Scientific Officer	Sale	1,000	$159.56	$160K	8,666	View ↗
2026-04-23	MATA NATHAN L.	Chief Scientific Officer	Sale	1,000	$166.28	$166K	9,666	View ↗

1–5 of 11

1 / 3

No recent congressional transactions.

No financial data available for BLTE.

Company may not file with SEC or CIK is unresolved.

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Belite Bio, Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference - Slideshow

Belite Bio, Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference Transcript